DYSLIPIDEMIA AND CARDIOVASCULAR DISEASE RISK

Abstract

Dyslipidemia is a key modifiable risk factor for cardiovascular disease, marked by abnormal lipid metabolism that drives atherosclerotic events. This thesis explores the pathophysiological links between lipid disorders and cardiovascular risk, reviewing current diagnostic tools and evidence-based treatments. Studies show that managing lipids through medication and lifestyle changes significantly lowers cardiovascular morbidity and mortality. The work also covers screening guidelines, risk assessment methods, and emerging therapies aimed at improving prevention.